NPI registry status
Active
2026 NPPES data Hematology & Oncology Physician NPI 1518910561 M.D.
Verify on CMS → Henry Xiong, M.D.
Hematology & Oncology Physician in Fort Worth, Texas.
This profile is drawn from the federal National Provider Identifier Registry (CMS NPPES), which lists more than 7 million U.S. healthcare providers - including 11,232 in Hematology & Oncology Physician, and covers specialty classification, practice address, and Medicare Part D prescribing data when reported. According to CMS, every field reflects the provider's official federal registration, see our methodology.
Federal data, no proprietary rating.
We show these CMS records as-is - no composite score, no star rating, no editorial opinion layered on top.
Prescribing volume
806
Medicare Part D claims · 115 beneficiaries · Hematology & Oncology Physician avg: 847
Generic prescribing
81%
generic claims · 19% brand-name · higher generic rates reduce patient out-of-pocket costs
MIPS score
75/100
CMS neutral threshold · no category scores published
Industry payments
$1.6K
21 payments · CMS Open Payments (Sunshine Act)
Source: CMS Medicare Part D Prescriber Public Use File, 2023
What the federal data shows
Henry Xiong, M.D. carries the neutral CMS MIPS final score of 75/100, assigned where no category was scored - and filed 806 Medicare Part D claims in 2023.
- 75/100
- CMS neutral score · not measured
- 806
- Part D claims, 2023
- 81%
- generic prescribing
- Likely
- board-certified (heuristic)
Every figure on this page comes straight from federal CMS records (NPPES, Medicare Part D, MIPS, Open Payments) - no proprietary rating or editorial opinion is applied.
CMS NPPES provider registry desk
NPI 1518910561 · Hematology & Oncology Physician
NPI-10 · ENUM-LEGACY · TAX-MID · MIPS-NEUTRAL · RX-LIGHT · BOOK-LIGHT · PHOTO-ENUM
- NPI-10 1518910561
- ENUM-LEGACY 2006
- TAX-MID 11K Hematology &
- MIPS-NEUTRAL 75/100
- RX-LIGHT 806
- BOOK-LIGHT 618 in Texas
- PHOTO-ENUM William Caceres · 2006
Henry Xiong, M.D.'s Medicare Part D volume vs every U.S. prescriber
Total Medicare Part D claims, 2023, across all CMS prescribers nationally
806 ≥ 73rd percentile 73% of 1,370,886 prescribers are in lower value bands
Each bar is a band; taller bars hold more prescribers. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.
The percentile is a conservative 100-claim band: it counts only prescribers in lower claim-volume bands. Medicare Part D claim volume is activity context, not a quality measure or recommendation. See methodology § corpus placement.
Source CMS Medicare Part D Prescriber Public Use File · 2023
✓
Board certification likely (heuristic, not verified)
Henry Xiong, M.D. practices in an ABMS-board-eligible specialty and shows active CMS Medicare participation + MIPS quality reporting + 1 hospital affiliation - signals consistent with board-certified status. For verified board certification, see CertificationMatters.org (the official ABMS public lookup).
What does the federal data show about Henry Xiong, M.D.?
CMS neutral score, not measuredPrimary specialty
Hematology & Oncology Physician
Medicare Part D claims
806 5% vs specialty avg
MIPS final score
75/100
Specialty distribution in Texas
How Hematology & Oncology Physician compares to other specialties among Texas providers
MIPS score not measured
CMS assigned a neutral 75/100 threshold
CMS did not publish any Quality, Cost, Promoting Interoperability, or Improvement Activities category score for this clinician. This administrative threshold is not comparable with the national average of clinicians whose MIPS score was measured.
How MIPS and board certification work
The Merit-based Incentive Payment System (MIPS) scores providers 0–100 across four performance categories: Quality, Cost, Promoting Interoperability, and Improvement Activities, weighted under 42 CFR §414.1380. Reporting is voluntary for many small practices, so absence of a MIPS score is not a quality signal.
Board certification through an ABMS or AOA member board signals voluntary post-licensure examination plus continuous Maintenance of Certification cycles. Verify any individual provider's status through certificationmatters.org (ABMS) or osteopathic.org (AOA).
Practice Address
Provider Details
| NPI | 1518910561 |
|---|---|
| Specialty | Hematology & Oncology Physician |
| Credentials | M.D. |
| Gender | Male |
| NPI Issued | 05/19/2006 |
CMS Quality Score (MIPS)
Merit-based Incentive Payment System (MIPS) scores from CMS, 2023 performance year.
75
Final Score
CMS neutral threshold · not measured
Reporting: Group practice
Hospital and facility affiliations
Facilities where Henry Xiong, M.D. bills Medicare from. Star ratings (1-5) are CMS Hospital Compare's "Hospital overall rating" - a composite of mortality, readmission, patient experience, safety, timely care, and efficient use of medical imaging measures. Source: CMS Care Compare.
Oncology Hematology Consultants, PA
Mineral Wells, TX
Affiliations sourced from CMS Doctors and Clinicians National Downloadable File; hospital ratings from CMS Hospital General Information dataset (cross-referenced by facility name + state).
Industry payments received (2024) - CMS Open Payments transparency data
The federal Physician Payments Sunshine Act (part of the Affordable Care Act) requires drug and medical-device manufacturers + group purchasing organizations to publicly report payments and other transfers of value to physicians and teaching hospitals. The data below covers 2024 for Henry Xiong, M.D.. Source: openpaymentsdata.cms.gov.
Total received
$1.6K
Largest payer
AstraZeneca Pharmaceuticals LP
Most common payment type
Food and Beverage
Industry payments are not necessarily indicators of bias, they include research funding, consulting fees for evidence-based work, royalties for inventions, food at conferences, and similar items. The disclosure exists for transparency. Read our methodology for how we interpret this data.
License & disciplinary context - Texas TMB 2023 annual report
Aggregate state board data only, NOT a determination of any individual provider's status. The figures below describe statewide disciplinary activity across all ~77K Texas medical licensees in 2023 - they are NOT specific to Henry Xiong, M.D.. To verify Henry Xiong, M.D.'s current license status, search the TMB public license lookup directly, or check the Federation of State Medical Boards (FSMB) verification service.
344
Total board actions, Texas 2023
Across 334 cases
4.47
Actions per 1,000 licensees
Texas statewide rate
probation
Most common action type
94 cases
TMB publishes annual disciplinary statistics as part of public-record reporting under each state's Administrative Procedure Act. See the full breakdown by action type and year on the Texas disciplinary trends page. Cross-checked against FSMB U.S. Medical Regulatory Trends.
Brand vs generic prescribing mix · Typical
Henry Xiong, M.D. - brand share 19.0%
Hematology & Oncology Physician average
19% brand-name claims vs 81% generic, on 806 2023 Medicare Part D claims.
The federal Medicare Part D Generic Dispensing Rate national benchmark sits near 90% generic / 10% brand for primary-care prescribers, per CMS Office of the Actuary 2024 estimates. Higher brand share is common in specialty prescribing where generic equivalents are not available.
Medicare Part D Prescribing Data
CMS Medicare Part D prescriber-level data for calendar year 2023.
806
Total Claims
$2.3M
Total Drug Cost
115
Medicare Beneficiaries
Prescribing Breakdown
- 30-Day Fills
- 1,027
- Total Day Supply
- 26,518
- Brand vs Generic
- 19% brand / 81% generic
- Brand Drug Cost
- $2.0M
- Generic Drug Cost
- $312K
- Opioid Claims
- 94 (11.7% rate)
- Antibiotic Claims
- 24
Patient Demographics
- Average Patient Age
- 72.4 years
- Avg HCC Risk Score
- 2.89
- Gender Split
- 48% female / 52% male
Top Prescribed Drugs (Medicare Part D)
Top drugs by claim count for calendar year 2023. Based on Medicare Part D data only.
What Henry Xiong, M.D. prescribes most
Top Medicare Part D drugs by claim count, 2023
- Anastrozole
Anastrozole
50 claims
- Hydrocodone-Acetam…
Hydrocodone-Acetaminophen
44 claims
- Mirtazapine
Mirtazapine
40 claims
- Ondansetron Odt
Ondansetron Odt
37 claims
- Pantoprazole Sodium
Pantoprazole Sodium
33 claims
- Prednisone
Prednisone
31 claims
- Gabapentin
Gabapentin
29 claims
- Tramadol Hcl
Tramadol Hcl
29 claims
| Drug | Claims |
|---|---|
| Anastrozole | 50 |
| Hydrocodone-Acetaminophen Hydrocodone/Acetaminophen | 44 |
| Mirtazapine | 40 |
| Ondansetron Odt Ondansetron | 37 |
| Pantoprazole Sodium | 33 |
| Prednisone | 31 |
| Gabapentin | 29 |
| Tramadol Hcl | 29 |
| Abiraterone Acetate | 20 |
| Dexamethasone | 20 |
* Counts below 11 are suppressed by CMS for patient privacy. Generic names shown where available from CMS Part D data.
Hematology & Oncology Physician Overview
How Henry Xiong, M.D. fits within the Hematology & Oncology Physician landscape nationally.
11,232
Hematology & Oncology Physician Providers in US
54
States with Hematology & Oncology Physician
847
Avg Claims per Provider
Henry Xiong, M.D.'s 806 claims are below the specialty average of 847.
Nationwide Hematology & Oncology Physician peers with similar MIPS or enrollment year
Two federal-record peer sets for Xiong, both outside Texas so the neighborhoods are not geographic containment.
Similar MIPS final score
Nearest same-specialty clinicians by CMS MIPS final score (75 here).
Same NPPES enumeration year (2006)
Same-specialty clinicians who entered the NPI registry in the same calendar year, outside this state.
Nearby Hematology & Oncology Physician Providers in Texas
Other clinicians with the same primary specialty enrolled in Texas, drawn from the same CMS NPPES roster as Xiong.
One of 618 Hematology & Oncology Physician providers enrolled in Texas, 5 are shown here.
Dr. Elham Abbasi-Hafshejani
M.D.
The Woodlands, TX
Dr. Muhammad Abid
M.D.
Lubbock, TX
Dr. Ambrose Aboud
MD
El Paso, TX
Dr. Joel Abramowitz
M.D., PHD
Houston, TX
Dr. John Adams
DO
Arlington, TX
Compare Hematology & Oncology Physician nationally: see state-by-state distribution →
Frequently Asked Questions
What is Henry Xiong, M.D.'s specialty? ▼
Henry Xiong, M.D. specializes in Hematology & Oncology Physician and practices in Fort Worth, Texas. Credentials: M.D..
How much does Henry Xiong, M.D. prescribe under Medicare Part D? ▼
In 2023, Henry Xiong, M.D. wrote 806 Medicare Part D claims totaling $2.3M in drug costs for 115 beneficiaries.
What is Henry Xiong, M.D.'s Medicare quality score? ▼
Henry Xiong, M.D. has a CMS MIPS Final Score of 75/100. CMS published no Quality, Promoting Interoperability, Improvement Activity or Cost score for this clinician, so the final score is the neutral performance threshold CMS assigns rather than a measured result. The average MIPS Final Score across the 454,083 clinicians with at least one published category score is 83.5; clinicians whose score CMS assigned without scoring any category are excluded from that average. Source: CMS Merit-based Incentive Payment System (MIPS) 2023.
Where is Henry Xiong, M.D. located? ▼
Henry Xiong, M.D. is located at 800 W MAGNOLIA AVE, Fort Worth, TX, 76104. Phone: (817) 759-7000.
What is Henry Xiong, M.D.'s NPI number? ▼
Henry Xiong, M.D.'s National Provider Identifier (NPI) is 1518910561, issued on 05/19/2006.
Does Henry Xiong, M.D. prescribe more brand-name or generic drugs? ▼
Henry Xiong, M.D.'s prescribing is 19% brand-name and 81% generic drugs by claim count, with $2.0M in brand drug costs.
Does Henry Xiong, M.D. prescribe opioids? ▼
Yes, Henry Xiong, M.D. had 94 opioid claims in 2023 with an opioid prescribing rate of 11.7%.
How many Hematology & Oncology Physician providers are there in the US? ▼
There are 11,232 Hematology & Oncology Physician providers across 54 states in the US. The average Hematology & Oncology Physician provider writes 847 Medicare Part D claims per year.
What drugs does Henry Xiong, M.D. prescribe most often? ▼
Based on 2023 Medicare Part D data, Henry Xiong, M.D.'s most frequently prescribed drugs include Anastrozole, Hydrocodone-Acetaminophen, Mirtazapine. This reflects Medicare Part D prescriptions only and does not include commercial insurance or other payer types.
Does Henry Xiong, M.D. accept Medicare? ▼
Henry Xiong, M.D. appears in CMS Medicare data with 806 Part D claims and 115 Medicare beneficiaries in 2023. Contact the provider's office directly to confirm current Medicare enrollment and accepted plans.
How can I verify Henry Xiong, M.D.'s credentials? ▼
Henry Xiong, M.D.'s NPI is 1518910561 with credentials M.D.. You can verify this through the NPPES NPI Registry, check state medical board records, and confirm board certification through the ABMS or AOA.
Data Sources
View source datasets and methodology notes
- Provider Directory
- CMS National Plan and Provider Enumeration System (NPPES), download.cms.gov/nppes, updated monthly. Contains NPI, specialty, credentials, and practice location.
- Specialty Classification
- NUCC Health Care Provider Taxonomy (nucc.org), the industry standard for classifying provider specialties in Medicare and Medicaid billing.
- Prescribing Data
- CMS Medicare Part D Prescriber Public Use File (2023). Includes claims, drug costs, beneficiaries, and opioid prescribing rates.
- Quality Performance
- CMS Merit-based Incentive Payment System (MIPS) - 2023 performance year.
- Limitations
- Provider data is self-reported to CMS. Prescribing data reflects Medicare Part D only and does not include commercial insurance, Medicaid, or cash prescriptions. Claims below 11 beneficiaries are suppressed by CMS for privacy.
See our complete data methodology for details on how we collect and process government data.
Data as of April 2026 (NPPES) / 2023 (Medicare Part D). Source: Centers for Medicare & Medicaid Services (CMS).
Disclaimer: Data from CMS NPPES and Medicare Part D. PlainDoctor does not rate or rank providers. Provider information is self-reported and may not be current. Always verify information directly with the provider. About · Methodology
Every figure on PlainDoctor is rendered directly from the federal CMS NPPES registry, Medicare Part D, MIPS, and Open Payments records, no number is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.